Clinical Trials Directory

Trials / Completed

CompletedNCT02641405

Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
126 (actual)
Sponsor
I.R.C.C.S. Fondazione Santa Lucia · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

It's already known the efficacy of Gait Analysis (GA) on evaluating gait modification on Parkinson's Disease (PD) Patients (1). On the other hand Proprioceptive Focal Stimulation seems be useful in symptoms amelioration in several neurological disease. Few studies have been performed in Parkinson's disease. A total of 126 patients suffering from PD will be recruited in 6 italian neurological centers. The study will be a cross-over multicenter study with the randomization of the sequence. The patients will be randomly assigned to 2 groups receiving for 8 weeks either the Equistasi medical device, or an equivalent placebo. Gait analysis will be recorded in each patient at the beginning and at the end of the treatment assigned. After 4 weeks of wash-out, the treatment will be crossed and a new gait analysis recording will be performed. Finally a last recording will be taken at the end of the last 8 weeks. Secondary outcome will be the MDS-UPDRS (Movement Disorder Society - Unified Parkinson Disease Rating Scale), PDQ-39 (Parkinson Disease 39 Questionnaire ), ABC (Activity Specific Balance Confidence Scale).

Conditions

Interventions

TypeNameDescription
DEVICEEquistasiEquistasi is a nanotechnology for proprioceptive focal stimulation. Every patient will receive three patches to be placed at C7 and at the gastrocnemial junction of both legs.
DEVICEInactive EquistasiInactive Equistasi will be given to every patient in the form of three patches to be placed at C7 and at the gastrocnemial junction of both legs.

Timeline

Start date
2015-11-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2015-12-29
Last updated
2021-01-12

Locations

6 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT02641405. Inclusion in this directory is not an endorsement.